Hypertrophic Cardiomyopathy Genotype–Phenotype Analysis in Lithuanian Single-Center Cohort

Hypertrophic cardiomyopathies (HCMs) are among the most common genetic disorders; however, they might be underdiagnosed. Sequencing core sarcomere gene panels remain the main diagnostic tool. We present the results of HCM genetic testing performed at Lithuania's tertiary care center. All patients with diagnosed or clinically suspected HCM underwent next-generation panel sequencing. Of 204 patients, 34 (16.7%) received a genetic diagnosis. The most commonly affected genes were <i>MYBPC3</i> and <i>MYH7</i>. Notably, two patients were found to have LEOPARD syndrome due to <i>PTPN11</i> gene variants. Our results indicate that patients with an identified pathogenic variant were diagnosed with HCM at a younger age and exhibited a more severe phenotype (greater septal wall thickness), although no clear correlation with family history was observed. In addition, four novel <i>MYBPC3</i> variants, c.3467dup, c.1503C>G, c.2610dup, and c.1251del, were identified.